Literature DB >> 27275938

PURLs: "Go low" or say "No" to aggressive systolic BP goals?

Margaret Day1, James J Stevermer2.   

Abstract

The SPRINT trial demonstrated the benefits--and risks--of reaching a systolic target <120 mm Hg in non-diabetic patients at high risk for CV events. Here's who might benefit.

Entities:  

Mesh：

Substances：

Year:  2016        PMID： 27275938      PMCID： PMC4863041     

Source DB:  PubMed          Journal:  J Fam Pract        ISSN： 0094-3509            Impact factor:   0.493


  15 in total

1.  Health outcomes associated with antihypertensive therapies used as first-line agents. A systematic review and meta-analysis.

Authors:  B M Psaty; N L Smith; D S Siscovick; T D Koepsell; N S Weiss; S R Heckbert; R N Lemaitre; E H Wagner; C D Furberg
Journal:  JAMA       Date:  1997-03-05       Impact factor: 56.272

2.  Hypertension among adults in the United States: National Health and Nutrition Examination Survey, 2011-2012.

Authors:  Tatiana Nwankwo; Sung Sug Yoon; Vicki Burt; Quiping Gu
Journal:  NCHS Data Brief       Date:  2013-10

3.  Guidelines for managing high blood pressure.

Authors:  David K Cundiff; Francois Gueyffier; James M Wright
Journal:  JAMA       Date:  2014-07-16       Impact factor: 56.272

4.  Let's Not SPRINT to Judgment About New Blood Pressure Goals.

Authors:  Eduardo Ortiz; Paul A James
Journal:  Ann Intern Med       Date:  2016-02-23       Impact factor: 25.391

5.  Randomised double-blind comparison of placebo and active treatment for older patients with isolated systolic hypertension. The Systolic Hypertension in Europe (Syst-Eur) Trial Investigators.

Authors:  J A Staessen; R Fagard; L Thijs; H Celis; G G Arabidze; W H Birkenhäger; C J Bulpitt; P W de Leeuw; C T Dollery; A E Fletcher; F Forette; G Leonetti; C Nachev; E T O'Brien; J Rosenfeld; J L Rodicio; J Tuomilehto; A Zanchetti
Journal:  Lancet       Date:  1997-09-13       Impact factor: 79.321

6.  Prevention of stroke by antihypertensive drug treatment in older persons with isolated systolic hypertension. Final results of the Systolic Hypertension in the Elderly Program (SHEP). SHEP Cooperative Research Group.

Authors: 
Journal:  JAMA       Date:  1991-06-26       Impact factor: 56.272

7.  Principal results of the Japanese trial to assess optimal systolic blood pressure in elderly hypertensive patients (JATOS).

Authors: 
Journal:  Hypertens Res       Date:  2008-12       Impact factor: 3.872

8.  Treatment of hypertension in patients 80 years of age or older.

Authors:  Nigel S Beckett; Ruth Peters; Astrid E Fletcher; Jan A Staessen; Lisheng Liu; Dan Dumitrascu; Vassil Stoyanovsky; Riitta L Antikainen; Yuri Nikitin; Craig Anderson; Alli Belhani; Françoise Forette; Chakravarthi Rajkumar; Lutgarde Thijs; Winston Banya; Christopher J Bulpitt
Journal:  N Engl J Med       Date:  2008-03-31       Impact factor: 91.245

9.  Usual versus tight control of systolic blood pressure in non-diabetic patients with hypertension (Cardio-Sis): an open-label randomised trial.

Authors:  Paolo Verdecchia; Jan A Staessen; Fabio Angeli; Giovanni de Simone; Augusto Achilli; Antonello Ganau; Gianfrancesco Mureddu; Sergio Pede; Aldo P Maggioni; Donata Lucci; Gianpaolo Reboldi
Journal:  Lancet       Date:  2009-08-15       Impact factor: 79.321

10.  Outcomes of combined cardiovascular risk factor management strategies in type 2 diabetes: the ACCORD randomized trial.

Authors:  Karen L Margolis; Patrick J O'Connor; Timothy M Morgan; John B Buse; Robert M Cohen; William C Cushman; Jeffrey A Cutler; Gregory W Evans; Hertzel C Gerstein; Richard H Grimm; Edward W Lipkin; K M Venkat Narayan; Matthew C Riddle; Ajay Sood; David C Goff
Journal:  Diabetes Care       Date:  2014-03-04       Impact factor: 19.112
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.